Literature DB >> 17092558

Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.

Rosimeire A Roela1, Dirce M Carraro, Helena P Brentani, Jane H L Kaiano, Daniel F Simão, Roberto Guarnieiro, Luiz Fernando Lopes, Radovan Borojevic, M Mitzi Brentani.   

Abstract

Using cDNA microarray assays we have observed a clear difference in the gene expression pattern between bone marrow stromal cells obtained from healthy children (CT) and from pediatric patients with either myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) associated with MDS (MDS-AML). The global gene function profiling analysis indicated that in the pediatric MDS microenvironment the disease stages may be characterized mainly by underexpression of genes associated with biological processes such as transport. Furthermore, a subset of downregulated genes related to endocytosis and protein secretion was able to discriminate MDS from MDS-AML.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092558     DOI: 10.1016/j.leukres.2006.10.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  15 in total

Review 1.  Mesenchymal stem cells in pathogenesis of myelodysplastic syndromes.

Authors:  Jingya Wang; Zhijian Xiao
Journal:  Stem Cell Investig       Date:  2014-08-21

2.  Alterations in hematopoietic microenvironment in patients with aplastic anemia.

Authors:  Irina N Shipounova; Tatiana V Petrova; Daria A Svinareva; Kira S Momotuk; Elena A Mikhailova; Nina I Drize
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

3.  Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.

Authors:  Olga Blau; Claudia Dorothea Baldus; Wolf-Karsten Hofmann; Gundula Thiel; Florian Nolte; Thomas Burmeister; Seval Türkmen; Ouidad Benlasfer; Elke Schümann; Annette Sindram; Mara Molkentin; Stefan Mundlos; Ulrich Keilholz; Eckhard Thiel; Igor Wolfgang Blau
Journal:  Blood       Date:  2011-09-23       Impact factor: 22.113

4.  Myeloid malignancies and the microenvironment.

Authors:  Claudia Korn; Simón Méndez-Ferrer
Journal:  Blood       Date:  2016-11-15       Impact factor: 22.113

5.  Mapping transcription mechanisms from multimodal genomic data.

Authors:  Hsun-Hsien Chang; Michael McGeachie; Gil Alterovitz; Marco F Ramoni
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

Review 6.  Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.

Authors:  Daniella B Kerbauy; H Joachim Deeg
Journal:  Exp Hematol       Date:  2007-11       Impact factor: 3.084

7.  Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.

Authors:  Tushar D Bhagat; Si Chen; Matthias Bartenstein; A Trevor Barlowe; Dagny Von Ahrens; Gaurav S Choudhary; Patrick Tivnan; Elianna Amin; A Mario Marcondes; Mathijs A Sanders; Remco M Hoogenboezem; Suman Kambhampati; Nandini Ramachandra; Iaonnis Mantzaris; Vineeth Sukrithan; Remi Laurence; Robert Lopez; Prafullla Bhagat; Orsi Giricz; Davendra Sohal; Amittha Wickrema; Cecilia Yeung; Kira Gritsman; Peter Aplan; Konrad Hochedlinger; Yiting Yu; Kith Pradhan; Jinghang Zhang; John M Greally; Siddhartha Mukherjee; Andrea Pellagatti; Jacqueline Boultwood; Britta Will; Ulrich Steidl; Marc H G P Raaijmakers; H Joachim Deeg; Michael G Kharas; Amit Verma
Journal:  Cancer Res       Date:  2017-07-06       Impact factor: 13.312

8.  Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.

Authors:  Miyoung Kim; Seungwoo Hwang; Kiejung Park; Seon Young Kim; Young Kyung Lee; Dong Soon Lee
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 9.  Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies.

Authors:  Livingstone Fultang; Luciana Gneo; Carmela De Santo; Francis J Mussai
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

10.  Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects.

Authors:  V André; D Longoni; S Bresolin; C Cappuzzello; E Dander; M Galbiati; C Bugarin; A Di Meglio; E Nicolis; E Maserati; M Serafini; A J Warren; G Te Kronnie; G Cazzaniga; L Sainati; M Cipolli; A Biondi; G D'Amico
Journal:  Blood Cancer J       Date:  2012-10-12       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.